Instrumento Inactivo

Otros idiomas Hercules Technology Growth Capital Inc Nasdaq

Acciones

US4270965084

Tiempo real estimado Cboe BZX Otros sitios de cotización 19:33:32 23/05/2024			Varia. Cinco días.	Varia. 1 de enero.
19,18 ^USD	0,00 %		0,00 %	0,00 %

17/05	HERCULES CAPITAL, INC. : Obtiene una recomendación neutral de UBS	ZM
09/05	X4 Pharmaceuticals recibe 125 millones de dólares de capital adicional; las acciones suben	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Hercules Capital : 2025 Proxy Statement	17/05
Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital	15/05
Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders	13/05
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS	10/05
Electric Hydrogen secures $100M credit facility from HSBC, J.P. Morgan, Stifel Bank and Hercules Capital to decarbonize critical industries at scale	10/05
X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise	09/05
Verona Pharma Signs Financing Agreements for Up to $650 Million	09/05
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility	09/05
Hercules Capital Announces Upcoming Event for the Financial Community	07/05
Hercules Capital: Q1 Earnings Snapshot	02/05
Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Hercules Capital Reports First Quarter 2024 Financial Results	02/05
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024	30/04
Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024	30/04
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment	30/04
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations	24/04
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call	18/04
KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million.	03/04
Hercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.	27/03
Bluebird bio to Restate Financial Statements; Shares Fall	26/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Hercules Technology Growth Capital Inc Nasdaq

Acciones

US4270965084

Otros idiomas

Filtros